(Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 44.73%18.96B | 17.83%59.28B | 3.75%41.32B | -8.05%27.42B | -2.84%13.1B | 48.25%50.31B | 124.90%39.83B | 151.71%29.83B | 84.49%13.48B | -46.72%33.93B |
Operating income | 44.73%18.96B | 17.83%59.28B | 3.75%41.32B | -8.05%27.42B | -2.84%13.1B | 48.25%50.31B | 124.90%39.83B | 151.71%29.83B | 84.49%13.48B | -46.72%33.93B |
Cost of sales | ---- | -14.75%-50.65B | ---- | 10.19%-24.06B | ---- | -39.87%-44.14B | ---- | -131.77%-26.79B | ---- | 44.59%-31.56B |
Operating expenses | -44.62%-16.2B | -14.75%-50.65B | -2.18%-35.06B | 10.19%-24.06B | 4.31%-11.2B | -39.87%-44.14B | -111.80%-34.31B | -131.77%-26.79B | -76.25%-11.7B | 44.59%-31.56B |
Gross profit | 45.42%2.76B | 39.89%8.63B | 13.54%6.26B | 10.88%3.36B | 6.84%1.9B | 159.67%6.17B | 265.57%5.52B | 948.68%3.03B | 166.59%1.78B | -64.72%2.38B |
Selling expenses | -60.94%-38.97M | 16.58%-147.18M | 34.46%-88.9M | 41.38%-59.09M | 58.03%-24.21M | 51.15%-176.42M | 40.34%-135.65M | 9.69%-100.81M | -250.18%-57.69M | -237.06%-361.15M |
Administrative expenses | -0.90%-600.06M | -6.05%-2.61B | 19.57%-1.79B | 5.76%-1.11B | 18.89%-594.7M | -2.33%-2.47B | -6.06%-2.23B | 17.33%-1.18B | 14.04%-733.21M | 14.90%-2.41B |
Research and development expenses | -40.49%-94.53M | -21.93%-487.2M | -11.26%-319.44M | 4.93%-164.92M | -16.52%-67.28M | -15.61%-399.57M | -40.73%-287.12M | -45.41%-173.47M | -20.06%-57.75M | 11.49%-345.61M |
Profit from asset sales | -92.36%84.29K | ---- | 168.05%429.37K | ---- | --1.1M | ---- | -9.66%-630.91K | ---- | ---- | ---- |
Revaluation surplus | 111.85%9.32M | ---- | 109.71%28.52M | ---- | -222.26%-78.66M | ---- | -167.44%-293.86M | ---- | -31.94%64.34M | ---- |
-Changes in the fair value of other assets | 111.85%9.32M | ---- | 109.71%28.52M | ---- | -222.26%-78.66M | ---- | -167.44%-293.86M | ---- | -31.94%64.34M | ---- |
Impairment and provision | 27.26%-8.95M | ---- | -1,971.98%-41.09M | ---- | -1,614.37%-12.31M | ---- | -58.71%2.2M | ---- | -63.54%812.91K | ---- |
-Other impairment is provision | 27.26%-8.95M | ---- | -1,971.98%-41.09M | ---- | -1,614.37%-12.31M | ---- | -58.71%2.2M | ---- | -63.54%812.91K | ---- |
Operating interest expense | ---- | ---- | ---- | -37.66%-702.32M | ---- | ---- | ---- | ---510.16M | ---- | 12.03%-732.64M |
Special items of operating profit | -114.15%-11.72M | -64.75%-482.22M | -43.47%58.6M | 90.95%-12.48M | 441.92%82.83M | -120.32%-292.7M | -70.70%103.67M | -141.80%-137.88M | -123.36%-24.22M | 488.65%1.44B |
Operating profit | 74.69%1.72B | 72.83%4.9B | 63.01%3.38B | 41.11%1.31B | 27.92%986.73M | 8,502.74%2.83B | 462.54%2.07B | 189.02%928.12M | 604.79%771.39M | -101.20%-33.71M |
Financing income | ---- | 70.42%145.11M | ---- | ---- | ---- | --85.15M | ---- | ---- | ---- | ---- |
Financing cost | -4.32%-334.19M | -49.22%-1.57B | -44.77%-1.12B | ---- | -55.96%-320.34M | ---1.05B | -42.15%-771.75M | ---- | -26.37%-205.4M | ---- |
Share of profits of associates | ---- | -56.80%15.24M | ---- | -7.56%18.02M | ---- | 61.65%35.27M | ---- | 120.17%19.5M | ---- | 104.52%21.82M |
Special items of earning before tax | -537.24%-17.83M | ---- | 52.21%-38.67M | ---- | 91.92%-2.8M | ---- | -934.62%-80.92M | ---- | -1,340.18%-34.61M | ---- |
Earning before tax | 106.71%1.37B | 83.37%3.49B | 82.21%2.22B | 40.11%1.33B | 24.88%663.59M | 16,093.94%1.9B | 210.35%1.22B | 171.47%947.62M | 267.23%531.39M | -100.42%-11.89M |
Tax | -98.18%-316.11M | -21.23%-664.97M | -33.54%-562.64M | 6.12%-347.86M | 9.47%-159.51M | -152.06%-548.53M | -46.59%-421.33M | -214.04%-370.53M | -383.70%-176.19M | 62.10%-217.62M |
After-tax profit from continuing operations | 109.41%1.06B | 108.54%2.82B | 107.92%1.66B | 69.79%979.83M | 41.92%504.09M | 689.85%1.35B | 157.30%797.61M | 139.97%577.09M | 200.29%355.2M | -110.19%-229.51M |
Earning after tax | 109.41%1.06B | 108.54%2.82B | 107.92%1.66B | 69.79%979.83M | 41.92%504.09M | 689.85%1.35B | 157.30%797.61M | 139.97%577.09M | 200.29%355.2M | -110.19%-229.51M |
Minority profit | 445.39%355.72M | 246.63%555.86M | 199.31%313.18M | 173.47%125.25M | 62.11%65.22M | 2,052.53%160.36M | 290.70%104.64M | 163.69%45.8M | 262.41%40.23M | -103.25%-8.21M |
Profit attributable to shareholders | 59.48%699.89M | 89.99%2.27B | 94.12%1.35B | 60.85%854.58M | 39.34%438.87M | 639.28%1.19B | 151.82%692.98M | 138.72%531.29M | 195.62%314.97M | -111.07%-221.3M |
Basic earnings per share | 85.71%0.13 | 110.53%0.4 | 130.00%0.23 | 55.56%0.14 | 40.00%0.07 | 290.00%0.19 | 133.33%0.1 | 129.03%0.09 | 183.33%0.05 | -121.74%-0.1 |
Diluted earnings per share | 85.71%0.13 | 110.53%0.4 | 130.00%0.23 | 55.56%0.14 | 40.00%0.07 | 290.00%0.19 | 133.33%0.1 | 129.03%0.09 | 183.33%0.05 | -121.74%-0.1 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
Auditor | -- | Shinnaganaka & Chung Certified Public Accountants (Special General Partnership) | -- | -- | -- | Shinnaganaka & Chung Certified Public Accountants (Special General Partnership) | -- | -- | -- | Nobunaga Zhonghe (Hong Kong) Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data